#Coronavirus Disease Research #References (by AMEDEO, May 25 ’24)

  1. KO HHT
    Potential consequences of ineffective COVID-19 antiviral management.
    Acad Emerg Med. 2024 May 20. doi: 10.1111/acem.14940.
    PubMed        


    Am J Respir Crit Care Med
  2. SPIESSHOEFER J, Regmi B, Senol M, Jorn B, et al
    Potential Diaphragm Muscle Weakness-related Dyspnea Persists Two Years after COVID-19 and Could Be Improved by Inspiratory Muscle Training: Results of an Observational and an Interventional Trial.
    Am J Respir Crit Care Med. 2024 May 19. doi: 10.1164/rccm.202309-1572.
    PubMed         Abstract available
  3. SALISBURY ML, Markin CR, Fadely TH, Guttentag AR, et al
    Impact of the COVID-19 Pandemic on a Program to Screen for Subclinical Familial Pulmonary Fibrosis.
    Am J Respir Crit Care Med. 2024 May 19. doi: 10.1164/rccm.202401-0034.
    PubMed        


    Ann Intern Med
  4. KEUTE K
    Healing the Sick: A Timeline of Altruism.
    Ann Intern Med. 2024;177:686-687.
    PubMed        
  5. CHOW EJ, Lynch JB, Zerr DM, Riedo FX, et al
    Lessons From the COVID-19 Pandemic: Updating Our Approach to Masking in Health Care Facilities.
    Ann Intern Med. 2024;177:689.
    PubMed        
  6. WEITZ HH, Merli GJ, Carson JL
    Web Exclusive. Annals Consult Guys – Acute Coronary Syndrome and Anemia: When to Transfuse?
    Ann Intern Med. 2024;177:eW240002.
    PubMed        
  7. IORIO A, Laine C
    What You May Have Missed in 2023: Keeping Up With the Constant Flow of New Medical Evidence.
    Ann Intern Med. 2024;177.
    PubMed        


    Antiviral Res
  8. LIANG Y, Xiao W, Peng Y, Zhang S, et al
    Development of Nanoparticle Vaccines Utilizing Designed Fc-Binding Homo-oligomers and RBD-Fc of SARS-CoV-2.
    Antiviral Res. 2024 May 21:105917. doi: 10.1016/j.antiviral.2024.105917.
    PubMed         Abstract available


    BMJ
  9. MAHENDRADHATA Y
    Presidential election brings a challenging future for evidence informed health policies in Indonesia.
    BMJ. 2024;385:q1119.
    PubMed        
  10. MCKEE M
    The Infected Blood Inquiry: we need some honesty and engagement by those in authority.
    BMJ. 2024;385:q1143.
    PubMed        
  11. DYER C
    Infected blood scandal: “Chilling” cover up hid truth for decades, public inquiry finds.
    BMJ. 2024;385:q1139.
    PubMed        
  12. TORJESEN I
    Wastewater management must have greater focus on protecting public health, says report.
    BMJ. 2024;385:q1142.
    PubMed        
  13. RIMMER A
    Physician associates must have a named senior doctor supervising them at all times, says BMA.
    BMJ. 2024;385:q1148.
    PubMed        
  14. YASSAIE R
    Doctors who are activists remind and inspire us also to do the work.
    BMJ. 2024;385:q1138.
    PubMed        
  15. DUNN K, Hamilton Hurwitz H, Toledo JP, Schwaber MJ, et al
    Summary of WHO infection prevention and control guideline for covid-19: striving for evidence based practice in infection prevention and control.
    BMJ. 2024;385:q645.
    PubMed        
  16. NAKWEYA G
    Severe budget cuts in Kenya will plunge country into health crisis, officials warn.
    BMJ. 2024;385:q1154.
    PubMed        
  17. BAHRI C
    The untold health toll of voting.
    BMJ. 2024;385:q1060.
    PubMed        

  18. Seven days in medicine: 15-21 May 2024.
    BMJ. 2024;385:q1130.
    PubMed        
  19. TORJESEN I
    Sixty seconds on . . . prepping.
    BMJ. 2024;385:q1161.
    PubMed        
  20. MURRAY I
    Covid inquiry: What have we learnt about Northern Ireland’s response?
    BMJ. 2024;385:q1160.
    PubMed        


    Emerg Infect Dis
  21. COCOROS NM, Eberhardt K, Nguyen VT, Brown CM, et al
    Electronic Health Record-Based Algorithm for Monitoring Respiratory Virus-Like Illness.
    Emerg Infect Dis. 2024;30:1096-1103.
    PubMed         Abstract available
  22. CHANG T, Cho SI, Yoo DS, Min KD, et al
    Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea.
    Emerg Infect Dis. 2024;30:1154-1163.
    PubMed         Abstract available
  23. GRIFFIN I, King J, Lyons BC, Singleton AL, et al
    Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States.
    Emerg Infect Dis. 2024;30:1144-1153.
    PubMed         Abstract available
  24. BANKERS L, O’Brien SC, Tapay DM, Ho E, et al
    SARS-CoV-2 Disease Severity and Cycle Threshold Values in Children Infected during Pre-Delta, Delta, and Omicron Periods, Colorado, USA, 2021-2022.
    Emerg Infect Dis. 2024;30:1182-1192.
    PubMed         Abstract available
  25. CUNNINGHAM-OAKES E, Pilgrim J, Darby AC, Appleton C, et al
    Emerging Variants of Canine Enteric Coronavirus Associated with Outbreaks of Gastroenteric Disease.
    Emerg Infect Dis. 2024;30:1240-1244.
    PubMed         Abstract available
  26. CERPAS C, Vasquez G, Moreira H, Juarez JG, et al
    Introduction of New Dengue Virus Lineages of Multiple Serotypes after COVID-19 Pandemic, Nicaragua, 2022.
    Emerg Infect Dis. 2024;30:1203-1213.
    PubMed         Abstract available
  27. CANO-TERRIZA D, Beato-Benitez A, Fernandez-Bastit L, Segales J, et al
    SARS-CoV-2 in Captive Nonhuman Primates, Spain, 2020-2023.
    Emerg Infect Dis. 2024;30:1253-1257.
    PubMed         Abstract available
  28. KINOSHITA R, Miyamoto S, Sakuraba S, Sugihara J, et al
    Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.
    Emerg Infect Dis. 2024;30:1267-1270.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol
  29. CHEA N, Eure T, Alkis Ramirez R, Zlotorzynska M, et al
    Characteristics of healthcare personnel with SARS-CoV-2 infection: 10 emerging infections program sites in the United States, April 2020-December 2021.
    Infect Control Hosp Epidemiol. 2024 May 21:1-9. doi: 10.1017/ice.2024.
    PubMed         Abstract available


    Int J Infect Dis
  30. CHEMAITELLY H, Akhtar N, Jerdi SA, Kamran S, et al
    Association between COVID-19 vaccination and stroke: a nationwide case-control study in Qatar.
    Int J Infect Dis. 2024 May 20:107095. doi: 10.1016/j.ijid.2024.107095.
    PubMed         Abstract available
  31. RAMONFAUR D, Ayad N, Liu PHZ, Zhou J, et al
    The global clinical studies of long COVID.
    Int J Infect Dis. 2024 May 21:107105. doi: 10.1016/j.ijid.2024.107105.
    PubMed         Abstract available
  32. LI Y, Wu Z, Yan Y, Shi Y, et al
    Corrigendum to “Prevalence of respiratory viruses among hospitalized children with lower respiratory tract infections during the COVID-19 pandemic in Wuhan, China” [International Journal of Infectious Diseases 139 (2024) pages 6-12].
    Int J Infect Dis. 2024;145:107056.
    PubMed        
  33. ZHANG D, Liu S, Peng B, Shi X, et al
    Effects of the timing of maternal SARS-CoV-2 infection and vaccination status on placental transfer of antibodies to neonates: a cross-sectional study.
    Int J Infect Dis. 2024 May 16:107098. doi: 10.1016/j.ijid.2024.107098.
    PubMed         Abstract available


    J Infect
  34. HAN B, Li XM, Li R, Ning W, et al
    Epidemiological Surveillance of Acute Respiratory Infections Based on Targeted Metagenomic Next Generation Sequencing During the Flu Season after COVID-19 Pandemic in Beijing.
    J Infect. 2024 May 22:106188. doi: 10.1016/j.jinf.2024.106188.
    PubMed        
  35. PATERNINA-CAICEDO A, Quevedo DS, Rios DS, Moyano D, et al
    Heterologous and BNT162b2 boosters are more effective than non-mRNA homologous boosters for Omicron.
    J Infect. 2024;88:106165.
    PubMed        


    J Med Virol
  36. HAQUE W, Talha M, Rahman S, Hasan M, et al
    Rotavirus trends and distribution of genotypes before and during COVID-19 pandemic era: Bangladesh, 2017-2021.
    J Med Virol. 2024;96:e29681.
    PubMed         Abstract available
  37. AMOROSO MG, Pucciarelli A, Serra F, Ianiro G, et al
    Ten different viral agents infecting and co-infecting children with acute gastroenteritis in Southern Italy: Role of known pathogens and emerging viruses during and after COVID-19 pandemic.
    J Med Virol. 2024;96:e29679.
    PubMed         Abstract available
  38. GONG S, Ma C, Ma R, Zhu T, et al
    Elevated pretreatment serum apolipoprotein E level associated with poor prognosis of patients with COVID-19 during the omicron BA.5 and BF.7 wave.
    J Med Virol. 2024;96:e29673.
    PubMed         Abstract available
  39. AKANCHISE T, Angelov B, Angelova A
    Nanomedicine-mediated recovery of antioxidant glutathione peroxidase activity after oxidative-stress cellular damage: Insights for neurological long COVID.
    J Med Virol. 2024;96:e29680.
    PubMed         Abstract available
  40. JEONG YD, Lee K, Lee S, Park J, et al
    Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database.
    J Med Virol. 2024;96:e29682.
    PubMed         Abstract available


    J Virol
  41. DOMINGO E, Martinez-Gonzalez B, Garcia-Crespo C, Somovilla P, et al
    Correction for Domingo et al., “Puzzles, challenges, and information reservoir of SARS-CoV-2 quasispecies”.
    J Virol. 2024 May 24:e0026324. doi: 10.1128/jvi.00263.
    PubMed        
  42. MA MT, Jiang Q, Chen C-H, Badeti S, et al
    S309-CAR-NK cells bind the Omicron variants in vitro and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.
    J Virol. 2024 May 20:e0003824. doi: 10.1128/jvi.00038.
    PubMed         Abstract available


    JAMA
  43. HARRIS E
    Monoclonal Antibody Authorized to Protect At-Risk People From COVID-19.
    JAMA. 2024 May 24. doi: 10.1001/jama.2024.8628.
    PubMed        
  44. DEVEREUX G, Cotton S, Nath M, McMeekin N, et al
    Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
    JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771.
    PubMed         Abstract available
  45. BOCK A
    Researchers See Hope in Symptom-Guided Exercise for Long COVID With Postexertional Malaise.
    JAMA. 2024;331:1609-1611.
    PubMed        


    Lancet
  46. SAMARASEKERA U
    50 years of the Expanded Programme on Immunization.
    Lancet. 2024;403:1971-1972.
    PubMed        

  47. Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024;403:2204-2256.
    PubMed         Abstract available
  48. MARCATO AJ, Meagher N, Spirkoska V, Arnott A, et al
    One Health pandemic preparedness: the role of companion animals in disease transmission.
    Lancet. 2024;403:1984-1985.
    PubMed        
  49. ADAMU AA, Ndwandwe D, Jalo RI, Muhammad ID, et al
    Cofinancing immunisation through national health insurance.
    Lancet. 2024;403:1983-1984.
    PubMed        
  50. HORTON R
    Offline: Indifference-the biggest threat to global health.
    Lancet. 2024;403:1970.
    PubMed        
  51. KANTER R, Fort MP
    Rethinking health policy: life expectancy and mortality in an era of polycrisis.
    Lancet. 2024;403:1956-1958.
    PubMed        


    Lancet Infect Dis
  52. INGHAMMAR M, Kahn F
    Immune evasiveness of SARS-CoV-2 variants and vaccine selection.
    Lancet Infect Dis. 2024 May 15:S1473-3099(24)00286.
    PubMed        
  53. MOUSTSEN-HELMS IR, Bager P, Larsen TG, Moller FT, et al
    Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.
    Lancet Infect Dis. 2024 May 15:S1473-3099(24)00220.
    PubMed         Abstract available
  54. KAKU Y, Uriu K, Kosugi Y, Okumura K, et al
    Virological characteristics of the SARS-CoV-2 KP.2 variant.
    Lancet Infect Dis. 2024 May 20:S1473-3099(24)00298.
    PubMed        


    MMWR Morb Mortal Wkly Rep
  55. TUTTLE A, Hughes CM, Dvorak M, Aeschleman L, et al
    Notes from the Field: Clade II Mpox Surveillance Update – United States, October 2023-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:474-476.
    PubMed        
  56. CLEMENS T, Moreland B, Mack KA, Thomas K, et al
    Vital Signs: Drowning Death Rates, Self-Reported Swimming Skill, Swimming Lesson Participation, and Recreational Water Exposure – United States, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:467-473.
    PubMed         Abstract available
  57. GUAGLIARDO SAJ, Kracalik I, Carter RJ, Braden C, et al
    Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine – United States, May 2022-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:460-466.
    PubMed         Abstract available


    Nature
  58. EWBANK J
    Trials that infected people with common colds can inform today’s COVID-19 challenge trials.
    Nature. 2024;629:757.
    PubMed        

  59. A global pandemic treaty is in sight: don’t scupper it.
    Nature. 2024;629:727.
    PubMed        
  60. WOOLSTON C
    How researchers in remote regions handle the isolation.
    Nature. 2024;629:1193-1195.
    PubMed        


    Pol J Radiol
  61. LYZNIAK P, Swieton D, Szurowska E
    Lung ultrasound in a nutshell. Lines, signs, some applications, and misconceptions from a radiologist’s point of view. Part 2.
    Pol J Radiol. 2024;89:e211-e224.
    PubMed         Abstract available


    Science
  62. BENGIO Y, Hinton G, Yao A, Song D, et al
    Managing extreme AI risks amid rapid progress.
    Science. 2024;384:842-845.
    PubMed         Abstract available
  63. KAISER J
    U.S. blocks funding for pandemic research group.
    Science. 2024;384:832-833.
    PubMed         Abstract available

Published by

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.